Nyxoah SA

NYXH · NYSE

$0.8344+$0.0124 (+1.51%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $0.822

About NYXH

Nyxoah SA is a medical technology company, which engages in the development and commercialization of solutions to treat Obstructive Sleep Apnea (OSA). The company is headquartered in Mont-Saint-Guibert, Brabant-Wallon and currently employs 154 full-time employees. The company went IPO on 2020-09-18. The firm focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.

Employees: 154
Headquarters: Mont-Saint-Guibert, Brabant-Wallon
Listed: Sep 18, 2020
Sector: Health Care
Industry: Health Care Equipment & Supplies
Website: nyxoah.com

Leadership

Nyxoah SA executives
Name	Title	Since	Age
Robert Taub	—	—	77
Olivier Taelman	—	2019	—
John Landry	—	—	51
Loic Moreau	—	—	—
Maurits Boon	—	—	—
Christoph Eigenmann	—	—	—
Scott Holstine	—	—	—
Francis Kim	—	—	—
Pierre Gianello	—	—	—
Virginia Kirby	—	—	—
Juergen Hambrecht	—	—	77
Rita Johnson-Mills	—	—	65
Kevin Rakin	—	—	63
Daniel Wildman	—	—	67

Similar companies

Companies in the same industry as Nyxoah SA

REMIRemedent

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.